A recent paper in PNAS (Swijnenburg et al., 2008) reveals that human embryonic stem cells are not immune privileged. Potential therapeutic use of these cells will thus depend on the development of new strategies to counter foreign graft rejection by patient immune systems.
|Pages (from-to)||357 - 358|
|Number of pages||2|
|Journal||Cell Stem Cell|
|Publication status||Published - 2008|